Orthomolecular Psychiatry: Varying the Concentrations of Substances Normally Present in the Human Body May Control Mental Disease

References

• , I might have described this therapy as the provision of the optimum molecular composition of the brain. The brain provides the molecular environment of the mind. I use the word mind as a convenient synonym for the functioning of the brain. The word orthomolecular may be criticized as a Greek-Latin hybrid. I have not, however, found any other word that expresses as well the idea of the right molecules in the right amounts.
   Google Scholar
• Følling A. Nord Med Tidskr 1934; 8: 1054, Z Physiol Chem 1934; 277: 169.
   Google Scholar
• Woolley D W. The Biochemical Bases of Psychoses. Wiley, New York 1962, See, for example
   Google Scholar
• Cherkin A. Science 1967; 155: 266
   PubMed Web of Science ®Google Scholar
• Pauling L. Science 1961; 134: 15, Miller S. Proc Nat Acad Sci US 1961; 47: 1515.
   PubMed Web of Science ®Google Scholar
• , The literature is so extensive that I refrain from giving references here.
   Google Scholar
• Stone I. Am J Phys Anthropol 1965; 23: 83, For references see The only other vertebrate known to require exogenous ascorbic acid is the red-vented bulbul. Psychonotus cater
   PubMedGoogle Scholar
• Beadle G W, Tatum E L. Proc Nat Acad Sci US 1941; 27: 499
   PubMedGoogle Scholar
• , The points in Fig. 2 represent my measurement of the slopes of the growth curves shown in Figure 1 of reference [8]. They agree closely with the points of Fig. 2 of reference [8] except for one point that for 1.2 μg I−1 which may have been misplotted.
   Google Scholar
• , The reported growth rate for the normal strain in a medium with 40 μg of added pyridoxine per liter is 3% greater than that for the basic medium, as shown by the slopes of the lines in reference [8], Fig. 1.
   Google Scholar
• Tatum E L, Beadle G W. Proc Nat Acad Sci US 1942; 28: 234
   Google Scholar
• Zamenhof S, Eichhorn H H. Nature 1967; 216: 465
   Google Scholar
• Michaelis L, Menten M. Biochem Z 1913; 49: 333
   Google Scholar
• Smith A DM. BMJ 1950; 11: 1840
   Google Scholar
• Edwin E, et al. Acta Med Scand 1965; 177: 689
   PubMedGoogle Scholar
• Hansen T, Rafaelson O J, Rødbro P. Lancet 1966; II, report serum B12 concentration below 150 pg ml−1 in 13 of 1000 consecutive patients admitted to a Copenhagen psychiatric clinic. Henderson JG et al. ibid., p. 809, report that nine of 1012 unselected psychiatric patients in a region in Scotland were found to have B12 deficiency, in addition to five pernicious anemia patients in the group.
   Google Scholar
• Cleckley H M, Sydenstricker V P, Geeslin L E. J Am Med Ass 1939; 112: 2107
   Google Scholar
• Sydenstricker V P, Cleckley H M. Am J Psychiat 1941; 99: 83, References are given in this paper to some earlier work on nicotinic acid therapy.
   Google Scholar
• Hoffer A, et al. J Clin Exp Psychopathol 1957; 18: 131, Hoffer A. Niacin Therapy in Psychiatry. Springfield: Thomas, 1962.
   PubMedGoogle Scholar
• Osmond H, Hoffer A. Lancet 1962; I: 316, (1962); review of a 9-year study
   Google Scholar
• Hoffer H, Osmond H. Acta Psychiat Scand 1964; 40: 171, Hoffer A. Int J Neuropsychiat 1966; 2: 234.
   PubMedGoogle Scholar
• Kyhos E D, Sevringhaus E L, Hagendorn D R. Arch Int Med 1945; 75: 407, For example, found that for some subjects 1.5 to 2.8 g per day were needed for saturation.
   Google Scholar
• Stone I. Perspect Biol Med 1967; 10: 135, Acta Genet Med Gemell 1966; 15: 345.
   Google Scholar
• Williams R J, Deason G. Proc Nat Acad Sci US 1967; 57: 1638
   PubMed Web of Science ®Google Scholar
• Akerfeldt S A. Science 1957; 125: 117
   PubMed Web of Science ®Google Scholar
• Benjamin J D. Psychosom Med 1958; 20: 427, Keyt SS. Science 1959; 129: 1528 1590.
   PubMed Web of Science ®Google Scholar
• Hoffer A, Osmond H. The Chemical Basis at Clinical Psychiatry. Thomas, Springfield 1960; 232, Briggs MH. New Zealand Med J 1962; 61: 229.
   Google Scholar
• Weil-Malherbe H. Biochem J 1936; 30: 665
   PubMedGoogle Scholar
• Price J G, Waelsch H, Putnam T J. J Am Med Ass 1944; 122
   Google Scholar
• Waelsch H. Am J Ment Defic 1948; 52: 305
   Google Scholar
• Zimmerman F T, Ross S. Arch Neurol Psychiat 1944; 51: 446
   Google Scholar
• Vogel W, Broverman D M, Draguns J G, Klaiber E L. Psychol Bull 1966; 65: 367, A recent survey of the role of glutamic acid in cognitive behaviors has been published by Many references to earlier work are given in this paper.
   PubMed Web of Science ®Google Scholar
• Zuckerkandl E, Pauling L. Horizons in Biochemistry, M Kasha, B Pullman. Academic Press, New York 1962; 189
   Google Scholar
• Pauling L, et al. Science 1949; 110: 543
   PubMed Web of Science ®Google Scholar
• Melander B, Martens S. Dis Nerv Syst 1958; 19: 478, It has been suggested by Acta Psychol Neurol Scand 1959; 34: 344 and by A Hoffer and H Osmond, Int J Neuropsychiat 1966; 2: 1, that the effects of taraxein [RG Heath, S Martens, BE Leach, M Cohen, CA Feigley, Am J Psychiat 1958; 114: 9[7] may result from changing the permeability of the blood-brain barrier.
   Google Scholar
• Huxley J, et al. Nature 1964; 204: 220
   PubMed Web of Science ®Google Scholar
• Book J A. Acta Genet Statist Med 1953; 4(I), Proc Int Congr Genet 10th 1958; 1: 81.
   Google Scholar
• Slater I E. Acta Genet Statist Med 1958; 8: 50
   PubMedGoogle Scholar